Previous close | 11.22 |
Open | 11.22 |
Bid | 11.25 |
Ask | 13.45 |
Strike | 60.00 |
Expiry date | 2025-11-21 |
Day's range | 11.22 - 11.22 |
Contract range | N/A |
Volume | |
Open interest | 3 |
PRINCETON, N.J., May 06, 2024--U.S. Food and Drug Administration Accepts Bristol Myers Squibb’s Application for Subcutaneous Nivolumab (nivolumab and hyaluronidase)
PRINCETON, N.J., May 06, 2024--European Medicines Agency Validates Bristol Myers Squibb’s Application for Opdivo (nivolumab) Plus Yervoy (ipilimumab) for the First-Line....
It's easy to match the overall market return by buying an index fund. When you buy individual stocks, you can make...